Pandemic Response
WHY THIS MATTERS IN BRIEF AI is increasingly good at identifying disease indicators, even beyond the level of human experts, and its use can accelerate…
WHY THIS MATTERS IN BRIEF If you want to develop a vaccine for a virus you need to be able to analyse and model it,…
WHY THIS MATTERS IN BRIEF Coronavirus tests have been in very short supply, and many simply don’t work, so wearables are being bought in to…
WHY THIS MATTERS IN BRIEF Globally Covid-19 lab testing facilities are under enormous pressure but robotic labs are arriving to help increase capacity. Interested…
WHY THIS MATTERS IN BRIEF During a time when people aren’t allowed out of their houses self-driving trucks are helping keep freight moving in the…
WHY THIS MATTERS IN BRIEF The ability to genetically sequence Covid-19 in real time means governments can slow its spread and and create vaccines faster….
WHY THIS MATTERS IN BRIEF Getting millions of people tested for coronavirus has become increasingly problematic and contentious, but to take this new test all…
WHY THIS MATTERS IN BRIEF As our mastery of synthetic biology improves so too does our ability to create new types of artificial bio-weaponry, and…
WHY THIS MATTERS IN BRIEF Today there are no vaccines for Covid-19 and complete vaccines will take at least 12 to 18 months to materialise,…
WHY THIS MATTERS IN BRIEF It takes years to develop vaccines, but when pandemics emerge you only have months and that’s not enough time so…
WHY THIS MATTERS IN BRIEF As Covid-19 continues its rampage around the world governments are finding new uses for some familiar technologies. Interested in…
WHY THIS MATTERS IN BRIEF Since the SARS and MERS pandemics there has been an explosion in technology innovation, including smartphones, which are now joining…
